High throughput analysis in HER2 positive locally advanced breast cancer: pCR and mutational status

被引：0
|
作者：
Paris, Ida
Minucci, Angelo
Generali, Daniele
Nanni, Simona
D'angelo, Tatiana
Pavese, Francesco
Fabi, Alessandra
De Bonis, Maria
Cannita, Katia
Piermattei, Alessia
Tiberi, Giordana
Fuso, Paola
Carbognin, Luisa
Rotondaro, Silvia
Nero, Camilla
Giacomini, Flavia
Pasciuto, Tina
Marrazzo, Maria
Giaco, Luciano
Mule, Antonino
Masetti, Riccardo
Franceschini, Gianluca
Garganese, Giorgia
Giannarelli, Diana
Scambia, Giovanni
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO4-01-02
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO4-01-02
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Her2/neu status in locally advanced breast cancer.
    Doran, CM
    Cameron, DA
    Watters, AD
    Leonard, RCF
    Bartlett, JMS
    BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (03) : 278 - 278
  • [2] Locally advanced breast cancer is associated with high rate of HER2 overexpression
    Bartlett, J
    Anderson, A
    Watters, A
    Leonard, R
    Cameron, D
    BRITISH JOURNAL OF CANCER, 2000, 83 : 37 - 37
  • [3] The effect of trastuzumab on pCR in locally advanced HER2-positive breast cancer.
    Lavasani, S. M.
    Pritchard, K. I.
    Kiss, A.
    Verma, S.
    Wright, F.
    Boileau, J.
    Trudeau, M. E.
    Czarnota, G. J.
    Dent, R. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (27)
  • [4] HER2 status in breast cancer patients: A comparison between borderline positive HER2 and strongly positive HER2 tumors
    Huszno, J.
    Nowara, E.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S137 - S137
  • [5] HER2 positive breast cancer
    Gianni, Luca
    Bianchini, Giampaolo
    CANCER RESEARCH, 2023, 83 (05)
  • [6] Salivary expression of soluble HER2 in breast cancer patients with positive and negative HER2 status
    Laidi, Fatna
    Bouziane, Amal
    Lakhdar, Amina
    Khabouze, Samira
    Rhrab, Brahim
    Zaoui, Fatima
    ONCOTARGETS AND THERAPY, 2014, 7 : 1285 - 1289
  • [7] IS THERE AN OPTIMAL TREATMENT SEQUENCE FOR HER2 POSITIVE ADVANCED BREAST CANCER?
    Arora, Shagun
    Swain, Sandra M.
    BREAST, 2015, 24 : S21 - S22
  • [8] HER2/neu expression in Venezuelan patients with locally advanced breast cancer
    Morales, Luisa
    Reigosa, Aldo
    Caleiras, Eduardo
    Mora, Richard
    Marrero, Nuria
    Payares, Eliecer
    Molina, Karla
    Sucre, Luis
    INVESTIGACION CLINICA, 2008, 49 (01): : 69 - 78
  • [9] Anti-HER2 Drugs for the Treatment of Advanced HER2 Positive Breast Cancer
    Stanowicka-Grada, Malwina
    Senkus, Elzbieta
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2023, 24 (11) : 1633 - 1650
  • [10] ESTROGEN RECEPTOR AS A NEGATIVE PREDICTOR OF COMPLETE PATHOLOGICAL RESPONSE IN HER2 POSITIVE LOCALLY ADVANCED BREAST CANCER
    Canario, Rita
    Cruz, Jorge
    Casalta-Lopes, Joao
    Goncalves, Bruno
    Mariano, Monica
    Broco, Sofia
    Pais, Ana
    Pazos, Isabel
    Carvalho, Teresa
    Pego, Antonio
    Madeira, Pedro
    Sousa, Gabriela
    Gervasio, Helena
    BREAST, 2015, 24 : S46 - S46
12345